Wing Kei Yip
Directeur Financier/CFO chez Rnaimmune, Inc.
Postes actifs de Wing Kei Yip
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
Rnaimmune, Inc.
 Rnaimmune, Inc. BiotechnologyHealth Technology Rnaimmune, Inc. develops a technology for the development of cancer therapies. It focuses on the areas such as infectious diseases, immuno oncology, and rare diseases. The company is headquartered in Gaithersburg, MD. | Directeur Financier/CFO | - | - |
Historique de carrière de Wing Kei Yip
Anciens postes connus de Wing Kei Yip
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| SIRNAOMICS LTD. | Directeur Financier/CFO | 15/11/2022 | 31/05/2024 |
| Corporate Officer/Principal | 01/12/2020 | 15/11/2022 | |
Rothschild (Hong Kong) Ltd.
 Rothschild (Hong Kong) Ltd. Investment ManagersFinance Part of Rothschild Concordia SAS, Rothschild (Hong Kong) Ltd. is a Chinese company that provides financial advisory services. The company is based in Hong Kong, Hong Kong. The CEO of the company is Yu Yu Yien. | Corporate Officer/Principal | 01/05/2010 | 01/08/2015 |
| KPMG Corporate Finance Ltd. | Corporate Officer/Principal | 01/08/2008 | 01/04/2010 |
Formation de Wing Kei Yip
| University of Hong Kong | Undergraduate Degree |
| The University of Chicago Booth School of Business | Masters Business Admin |
Statistiques
Internationale
| Hong Kong | 4 |
| Etats-Unis | 3 |
| Japon | 2 |
Opérationnelle
| Corporate Officer/Principal | 3 |
| Director of Finance/CFO | 2 |
| Undergraduate Degree | 1 |
Sectorielle
| Finance | 3 |
| Consumer Services | 3 |
| Health Technology | 3 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| SIRNAOMICS LTD. | Health Technology |
| Entreprise privées | 3 |
|---|---|
| KPMG Corporate Finance Ltd. | Finance |
Rothschild (Hong Kong) Ltd.
Rothschild (Hong Kong) Ltd. Investment ManagersFinance Part of Rothschild Concordia SAS, Rothschild (Hong Kong) Ltd. is a Chinese company that provides financial advisory services. The company is based in Hong Kong, Hong Kong. The CEO of the company is Yu Yu Yien. | Finance |
Rnaimmune, Inc.
Rnaimmune, Inc. BiotechnologyHealth Technology Rnaimmune, Inc. develops a technology for the development of cancer therapies. It focuses on the areas such as infectious diseases, immuno oncology, and rare diseases. The company is headquartered in Gaithersburg, MD. | Health Technology |
- Bourse
- Insiders
- Wing Kei Yip
- Expérience
